Benign Centrally-Located Intracranial Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Benign Centrally-Located Intracranial Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03028246

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

The goal of this prospective, non-randomized, single-arm, feasibility study is to develop data to evaluate the safety and feasibility of ExAblate 4000 treatment…

United States20 participantsStarted 2017-02-28

Treatment: ExAblate 4000 System

Benign Centrally-Located Intracranial Tumors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

All recent trials (1 shown)